Francine Horhey

Doctor of Medicine,  The Johns Hopkins Hospital 

Location: India

Consulting Services

Biostatistics Research Consulting Admin and Customer Support Legal Support

Areas Of Interest

Spongiform Encephalopathies, Transmissible Animal Nutritional Physiology Inferior Colliculus Color, Eye Reperfusion, Myocardial Points, Trigger Geography rhoA GTP-Binding Protein Receptor, Guanyl Cyclase-C Thoracic Nerve Lymphadenopathies, Tick-Borne Oxoacids Genu Valgums Analyses, Genetic Linkage Transcription Factor, MafG Silver, Methenamine NAD Agmatine ADP Ribosyltransferase Outpatient Monitoring Cobblestone Lissencephaly Capsules, External Carbamoyl-Phosphate Synthetase I Heart Septal Defects Receptor, PTH-2 Colors, Skin Ethics, Normative Marburg Virus Disease Arteries, Temporal Oral Contraceptives, Low Dose Lipomin RNA Polymerase II Transcription Factor D Exposures, Environmental Lipoprotein

Professional Narrative

Dr. Francine Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Executive Director, Amgen 2009
Senior Director, Amgen 2000

Education

Bachelor of science in nursing, Baylor College 2005
Master of Science in physician assistant, Baylor College 2004

Referees


Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :